IP Q1 2026 Earnings Modest EPS Beat Supports Positive Sentiment GGAL Q1 2026 Earnings EPS Misses Estimates Amid Challenging Argentine Macro Environment VREX Q1 2026 Earnings Earnings Slightly Miss Estimates Amid Operational Margin Headwinds Tango Therapeutics Q1 2026 Earnings Slight EPS Miss as PreRevenue Biotech Focuses on Pipeline Progress MSA Safety MSA Q1 2026 Earnings Earnings Beat as EPS Surges Past Estimates LOAN Q1 2026 Earnings EPS Slightly Misses Estimates Stock Declines